DRNA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals...

Stats
Dagens volum	5.54M
Gjennomsnittsvolum	3.03M
Markedsverdi	0.00
EPS	$-0.220 ( Q3 \| 2021-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.989 (2.59%)

AADI -6.52%

ABCL 0.73%

ABCM 0.04%

ABEO -3.20%

ABIO -0.30%

ABOS 4.65%

ABSI 2.55%

ABUS -0.98%

ABVX -3.00%

ACAD -0.38%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 2.91%

ACIU 0.00%

ACLX -0.61%

ACRV -4.79%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -4.01%

ADGI 0.87%

ADIL -3.65%

ADMA -1.32%

ADPT 0.15%

ADTX -3.47%

ADVM 0.72%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -2.97%

AGEN -3.80%

AGIO -2.64%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.08%

AKRO -2.70%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.99%

ALEC -0.57%

ALGS -3.00%

ALKS 1.72%

ALLK -11.44%

ALLO -4.17%

ALLR -1.49%

ALNA 3.16%

ALNY 2.20%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -15.94%

ALVR -0.88%

ALXN 0.00%

ALXO -11.28%

ALZN 5.10%

AMRN -2.79%

AMTI -3.13%

ANAB 1.05%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 4.04%

ANPC -3.15%

APGE 1.56%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.16%

APLT 0.79%

APM 1.26%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 0.38%

ARAV -13.39%

ARCT -6.70%

ARDS -12.13%

ARDX 1.66%

ARGX -0.57%

ARNA 0.00%

ARPO -0.90%

ARQT -2.14%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.28%

ARWR -2.42%

ASLN -4.68%

ASMB -5.58%

ASND -2.42%

ATAI -3.33%

ATHA 6.85%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.83%

ATRA -5.46%

ATXI 2.68%

ATXS -0.78%

AUPH -0.99%

AURA 4.55%

AUTL -3.45%

AVBP -4.46%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -1.03%

AVTX -3.67%

AVXL -5.56%

AXLA 0.00%

AXSM -1.27%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.24%

BCAB -6.23%

BCDA -0.85%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.07%

BCRX 1.81%

BCTX 12.24%

BCTXW 13.02%

BCYC 0.90%

BDRX -2.97%

BDTX 1.07%

BEAM 2.82%

BFRA -2.91%

BGNE -2.97%

BIOR -4.46%

BIVI 1.71%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.21%

BLTE -1.44%

BLU 0.03%

BLUE -4.91%

BMEA -16.12%

BMRN 0.24%

BNOX 4.46%

BNTC -3.06%

BNTX -1.58%

BOLD -11.17%

BOLT -0.19%

BPMC -2.26%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -3.77%

BTAI 14.83%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 1.70%

CABA 0.55%

CADL 0.71%

CALA 0.00%

CALC -10.43%

CALT -1.59%

CAPR 0.00%

CARA -11.44%

CARM 7.39%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.22%

CCCC -2.23%

CCXI 0.00%

CDAK 0.00%

CDIO -4.74%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.43%

CDXS 9.66%

CELC -3.64%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.47%

CERO -3.40%

CEROW -10.18%

CFRX -27.95%

CGEM -0.55%

CGEN -3.59%

CGON -2.96%

CGTX -3.98%

CHMA -6.00%

CHRS 4.75%

CINC 0.00%

CING -1.37%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.64%

CLGN -0.60%

CLLS -3.11%

CLNN -1.39%

CLNNW 0.00%

CLRB 5.93%

CLSD -2.53%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.84%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -33.10%

CNST 0.00%

CNTA 0.28%

CNTB -1.50%

CNTX -5.02%

COCP -1.42%

COEPW 32.45%

COGT -2.83%

CORT 3.36%

COYA 0.49%

CPRX -1.68%

CRBP -2.09%

CRBU -7.95%

CRDF 2.21%

CRGX -0.37%

CRIS -2.64%

CRNX -5.86%

CRSP 1.12%

CRTX 2.63%

CRVO -3.03%

CRVS 0.28%

CSBR -0.20%

CTCX 1.20%

CTIC 0.06%

CTMX -4.94%

CTNM 3.69%

CTXR -4.46%

CUE -2.77%

CVAC -5.92%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 19.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.55%

CYTO 0.00%

DARE 0.86%

DAWN -0.26%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.76%

DNLI -2.10%

DNTH -3.05%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW -0.04%

DRUG -0.10%

DSGN -2.57%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR 2.70%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.56%

ELEV -2.28%

ELOX 10.77%

ELTX -3.38%

ELVN 0.00%

ELYM 5.30%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -1.06%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.30%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 4.81%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.17%

ETON 2.59%

ETTX 0.00%

EVAX -2.14%

EVGN 2.77%

EVLO 0.00%

EWTX -0.29%

EXAI -0.57%

EXEL 0.56%

EYEG -0.69%

EYEN 0.02%

EYPT 0.12%

FATE -12.23%

FBIO 1.20%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.02%

FDMT -4.98%

FENC -2.58%

FGEN -9.83%

FHTX 9.35%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.77%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.01%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -1.35%

GANX -0.84%

GBIO -1.59%

GBT 0.01%

GDTC 0.50%

GERN -1.44%

GHRS -4.31%

GLMD -3.02%

GLPG -1.85%

GLSI 9.23%

GLTO -3.90%

GLUE -2.37%

GLYC -14.59%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -5.03%

GNPX -4.41%

GNTA 3.94%

GOSS -8.74%

GOVX -5.24%

GOVXW 10.89%

GPCR -7.14%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.14%

GRTX -1.66%

GTHX 3.64%

GUTS -0.23%

GXGXW 41.67%

GYRE -6.30%

HALO -1.18%

HARP 0.09%

HCWB -10.05%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.15%

HOOK 2.03%

HOTH -0.82%

HOWL 0.64%

HRMY 2.23%

HRTX 8.69%

HSTO 0.00%

HUMA 1.01%

HUMAW -6.25%

IBRX -6.46%

ICCC -2.10%

ICPT 0.21%

ICU 18.48%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.29%

IFRX -3.08%

IGMS -1.90%

IKNA -0.89%

IKT 0.00%

IMAB -0.29%

IMCR -3.50%

IMGN 0.02%

IMGO 0.00%

IMMP 5.73%

IMMX -5.19%

IMNM 3.99%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -4.18%

IMTX -1.17%

IMTXW 6.00%

IMUX -2.78%

IMV 0.00%

IMVT -3.77%

INAB -1.68%

INBX -2.98%

INCY -1.97%

INDP 6.88%

INFI -52.38%

INKT -0.46%

INM 3.18%

INMB 3.78%

INO 2.34%

INSM -0.89%

INTS -3.73%

INVA 0.62%

INZY 1.49%

IOBT -7.87%

IONS 1.21%

IOVA -4.02%

IPA 3.00%

IPHA 5.08%

IPSC -2.34%

IRON -2.04%

ISEE 0.38%

ITOS 2.60%

ITRM 1.52%

IVA 6.96%

IVVD 0.00%

JAGX 0.52%

JANX -4.78%

JAZZ -1.00%

JNCE 0.00%

JSPR -2.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.47%

KALV -2.55%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -8.89%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.45%

KRRO -2.12%

KRTX 0.03%

KRYS 0.69%

KTRA 10.32%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -3.44%

KYTX -5.17%

KZIA 7.51%

KZR -1.68%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.65%

LENZ -3.17%

LEXX -0.77%

LEXXW -14.63%

LGND -0.92%

LGNDV 0.00%

LGVN -9.84%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -4.36%

LPTX -2.75%

LQDA 0.41%

LRMR -1.49%

LSTA -1.68%

LTRN 5.74%

LUMO 0.67%

LVTX -4.59%

LXEO -11.92%

LXRX -2.06%

LYEL -35.45%

LYRA 4.18%

MACK 0.10%

MBIO -9.56%

MBRX -1.43%

MCRB 1.60%

MDGL -1.91%

MDNA -13.16%

MDWD 3.18%

MDXG -1.69%

MEIP 0.70%

MESO -1.63%

MGNX -5.59%

MGTA -7.74%

MGTX -0.95%

MGX -0.54%

MIRM -0.57%

MIRO 0.59%

MIST 2.48%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.67%

MLYS -7.48%

MNKD -0.86%

MNMD 3.15%

MNOV 1.41%

MNPR -8.59%

MOLN 0.76%

MOR 0.62%

MORF -3.15%

MREO 0.14%

MRKR -0.43%

MRNA -10.36%

MRNS -6.25%

MRSN -4.05%

MRTX -0.17%

MRUS 0.37%

MRVI 0.73%

MTCR -1.29%

MTEM 7.67%

MTP -18.50%

MURA -3.87%

MYMD 1.08%

NAMS 0.08%

NAMSW 0.64%

NAUT 0.66%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 4.50%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.28%

NLSP 2.88%

NLSPW 26.67%

NMRA -0.97%

NMTR -42.97%

NOVN -24.84%

NRBO 15.02%

NRIX -1.25%

NRSN 0.80%

NRSNW 0.00%

NRXP -7.43%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.75%

NTRBW -31.07%

NUVL -1.84%

NVAX -5.85%

NVCT -7.61%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 3.30%

OABIW -10.06%

OBIO 1.46%

OBSV 0.00%

OCEA -3.65%

OCGN 6.75%

OCS -1.00%

OCUL 0.69%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.69%

OMER -2.31%

OMGA -2.08%

ONCO 6.37%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.49%

ONTX -0.47%

ONVO 3.72%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -2.67%

ORMP 16.33%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.83%

OVID 0.00%

OYST 0.00%

PALI -0.48%

PASG 0.88%

PBLA -7.50%

PBM -3.44%

PBYI 3.89%

PCSA 0.00%

PCVX 0.99%

PDSB -6.33%

PEPG 1.37%

PGEN -6.29%

PHAR 1.99%

PHAS 0.00%

PHAT 0.00%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.65%

PHXM -5.20%

PIRS -1.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.84%

PLUR 10.75%

PMN -5.55%

PMVP -2.08%

PNT 0.16%

PPBT -2.98%

PRAX 5.12%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 0.67%

PRQR 0.60%

PRTA -3.03%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT -0.85%

PTE -0.82%

PTGX 0.21%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.56%

QNCX 1.93%

QNRX 0.87%

QSI -30.35%

QSIAW -9.44%

QTTB 2.91%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -2.11%

RARE 1.88%

RCKT -10.10%

REGN -0.21%

RENB -4.02%

REPL -3.06%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.61%

RGNX -6.25%

RIGL -6.24%

RLAY -5.65%

RLMD 0.33%

RLYB -5.02%

RNA 2.16%

RNAC -2.60%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -2.17%

RPRX -0.87%

RPTX -1.32%

RUBY 2.70%

RVLP -32.05%

RVMD -0.44%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.98%

RYTM -6.08%

RYZB 0.02%

RZLT 2.84%

SABS -1.37%

SABSW -5.53%

SAGE -0.73%

SANA -2.21%

SAVA -3.30%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.62%

SCPH 10.86%

SCPS 0.00%

SEEL -4.78%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.61%

SGMT -5.07%

SGTX -2.56%

SIOX 22.63%

SLDB -3.28%

SLGL 5.23%

SLN -8.28%

SLNO 0.72%

SLRX -0.81%

SLS -3.41%

SMMT -3.37%

SNDX 2.00%

SNGX 3.40%

SNPX -0.69%

SONN 0.54%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.37%

SRNE 0.00%

SRPT -0.91%

SRRA 0.00%

SRRK -1.55%

SRZN -2.45%

STAB 0.00%

STOK -6.95%

STRO -3.18%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA -4.08%

SWTX -0.34%

SYBX 0.00%

SYRS -1.98%

TALS -0.73%

TARA -10.45%

TARS -2.32%

TBPH 0.00%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.59%

TCRX -0.81%

TECH -1.53%

TENX -0.32%

TERN -7.03%

TFFP -12.18%

TGTX -7.89%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.53%

TNGX -3.46%

TNXP -10.00%

TNYA -4.56%

TPST 5.58%

TRDA -5.01%

TRVI 1.92%

TRVN 3.19%

TSHA -18.70%

TSVT -4.24%

TTNP -6.05%

TVTX 3.64%

TYRA -7.13%

UBX -2.13%

UNCY -4.00%

URGN 3.09%

UTHR -0.34%

VACC 11.36%

VALN -2.96%

VAXX 126.67%

VBIV -1.14%

VBLT -8.77%

VCEL 1.51%

VCNX 8.64%

VCYT -0.97%

VERA -4.00%

VERU 1.30%

VERV -3.54%

VIGL -0.27%

VINC 2.81%

VIR -0.98%

VIRI -5.66%

VIRX 3.85%

VKTX -1.66%

VLON -13.04%

VNDA -3.09%

VOR -6.05%

VRCA 1.69%

VRDN -3.49%

VRNA -2.03%

VRPX 3.73%

VRTX -0.06%

VSTM 4.74%

VTGN -2.11%

VTVT 1.28%

VTYX -1.46%

VXRT -1.32%

VYGR -0.77%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.49%

XBIO 1.03%

XBIT 6.29%

XCUR 0.23%

XENE -0.72%

XERS 5.63%

XFOR 5.70%

XLO 3.32%

XLRN 0.00%

XNCR -0.05%

XOMA -8.41%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.76%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.81%

ZNTL -1.31%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2021-12-28	Koppel Adam	Sell	3 080 237	Common Stock
2021-12-28	Koppel Adam	Sell	3 333	Restricted Stock Units
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)
2021-12-28	Koppel Adam	Sell	25 000	Director Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 12 087 \| Sell: 8 528 928

Volum Korrelasjon

Lang: 0.55 (weak)

Kort: 0.93 (very strong)

Signal:(82.281) Expect same movement, but be aware

Dicerna Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
ADMS	0.97
QADB	0.913
TYHT	0.901
DCRCU	0.898
FLXN	0.885
APOP	0.864
CNST	0.858
CNBKA	0.854
LCYAU	0.846
ICON	0.824

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Dicerna Pharmaceuticals Korrelasjon - Valuta/Råvare

0.35
( neutral )

-0.50
( neutral )

0.85
( strong )

0.45
( neutral )

-0.30
( neutral )

-0.64
( weak negative )

Dicerna Pharmaceuticals Økonomi

Annual	2020
Omsetning:	$164.31M
Bruttogevinst:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2020
Omsetning:	$164.31M
Bruttogevinst:	$164.31M (100.00 %)
EPS:	$-1.520

FY	2019
Omsetning:	$23.90M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.760

FY	2018
Omsetning:	$6.18M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.600

Financial Reports:

No articles found.

Dicerna Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk A/S.